Skip to main content

Table 2 Baseline characteristics of patients

From: Effects of financial incentives for treatment supporters on tuberculosis treatment outcomes in Swaziland: a pragmatic interventional study

  Control (N, %) Intervention (N, %) p-value
Total 916 161  
Male sex 457 (50.1) 72 (44.7) 0.203
Age    
0–14 years 172 (18.8) 27 (16.8) 0.545
15–34 years 410 (44.8) 76 (47.2) 0.565
≥35 years 333 (36.4) 57 (35.4) 0.817
Unknown 1 (0.1) 1 (0.6)  
TB category    
I (any new case) 671 (73.3) 130 (80.7) 0.051
II (previously treated TB/TB meningitis) 135 (14.8) 14 (8.7) 0.039*
III (children under 8) 107 (11.7) 17 (10.6) 0.671
Unknown 3 (0.3) 0 (0)  
Pulmonary disease 650 (71.0) 120 (74.5) 0.601
HIV status    
Reactive 707 (77.4) 111 (68.9) 0.021*
Non-reactive 184 (20.2) 47 (29.2) 0.010*
Test not done 18 (2.0) 2 (1.2) 0.755
Unknown 4 (0.4) 1 (0.6)  
On HIV treatment 521 (73.7) 90 (81.1) 0.160
  1. *p-value <0.05 i.e. statistically significant